Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

María Buti

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Medicina Clinica|November 9, 2007
[Adefovir dipivoxil compassionate use program in Spain: efficacy and resistance analysis]María Buti, Francisco Rodríguez Frías, José Luis Calleja, et al.
Annals of Hepatology|June 14, 2014
PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis CJavier Ampuero, José A Del Campo, Lourdes Rojas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 19, 2025
Beyond Risk Factors: Rethinking Hepatitis B and Hepatitis C Screening in Primary CareElena Vargas-Accarino, Ariadna Rando-Segura, María Asunción Úbeda, et al.
Viruses|February 26, 2022
Inspecting the Ribozyme Region of Hepatitis Delta Virus Genotype 1: Conservation and VariabilityBeatriz Pacin-Ruiz, María Francesca Cortese, David Tabernero, et al.
Plos One|June 26, 2018
Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin studyMaría Buti, María L Manzano, Rosa M Morillas, et al.
Journal of Gastroenterology and Hepatology|January 21, 2020
Significant decrease in the prevalence of hepatitis C infection after the introduction of direct acting antiviralsSergio Rodríguez-Tajes, Ángela Domínguez, Jose Antonio Carrión, et al.
European Journal of Gastroenterology & Hepatology|December 22, 2018
Hepatitis B surface antigen loss after discontinuing nucleos(t)ide analogue for treatment of chronic hepatitis B patients is persistent in White patientsEmilio Suárez, María Buti, Manuel Rodríguez, et al.
Plos One|September 13, 2017
Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin studyMaría Buti, María L Manzano, Rosa M Morillas, et al.
JHEP Reports : Innovation in Hepatology|December 11, 2023
Integrating viral hepatitis management into the emergency department: A further step towards viral hepatitis eliminationJordi Llaneras, Juan Carlos Ruiz-Cobo, Ariadna Rando-Segura, et al.
Journal of Virological Methods|December 18, 2020
Reflex viral load testing in dried blood spots generated by plasma separation card allows the screening and diagnosis of chronic viral hepatitisJoan Martínez-Campreciós, Ariadna Rando-Segura, María Buti, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Medicina Clinica|November 9, 2007
[Adefovir dipivoxil compassionate use program in Spain: efficacy and resistance analysis]María Buti, Francisco Rodríguez Frías, José Luis Calleja, et al.
Annals of Hepatology|June 14, 2014
PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis CJavier Ampuero, José A Del Campo, Lourdes Rojas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 19, 2025
Beyond Risk Factors: Rethinking Hepatitis B and Hepatitis C Screening in Primary CareElena Vargas-Accarino, Ariadna Rando-Segura, María Asunción Úbeda, et al.
Viruses|February 26, 2022
Inspecting the Ribozyme Region of Hepatitis Delta Virus Genotype 1: Conservation and VariabilityBeatriz Pacin-Ruiz, María Francesca Cortese, David Tabernero, et al.
Plos One|June 26, 2018
Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin studyMaría Buti, María L Manzano, Rosa M Morillas, et al.
Journal of Gastroenterology and Hepatology|January 21, 2020
Significant decrease in the prevalence of hepatitis C infection after the introduction of direct acting antiviralsSergio Rodríguez-Tajes, Ángela Domínguez, Jose Antonio Carrión, et al.
European Journal of Gastroenterology & Hepatology|December 22, 2018
Hepatitis B surface antigen loss after discontinuing nucleos(t)ide analogue for treatment of chronic hepatitis B patients is persistent in White patientsEmilio Suárez, María Buti, Manuel Rodríguez, et al.
Plos One|September 13, 2017
Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin studyMaría Buti, María L Manzano, Rosa M Morillas, et al.
JHEP Reports : Innovation in Hepatology|December 11, 2023
Integrating viral hepatitis management into the emergency department: A further step towards viral hepatitis eliminationJordi Llaneras, Juan Carlos Ruiz-Cobo, Ariadna Rando-Segura, et al.
Journal of Virological Methods|December 18, 2020
Reflex viral load testing in dried blood spots generated by plasma separation card allows the screening and diagnosis of chronic viral hepatitisJoan Martínez-Campreciós, Ariadna Rando-Segura, María Buti, et al.
Pageof 10